Treatment with semaglutide, a GLP-1 receptor agonist, improves extracellular matrix remodeling in the pancreatic islet of diet-induced obese mice
Luiz E.M. Cardoso, Thatiany de Souza Marinho, Fabiane Ferreira Martins, Márcia Barbosa Águila, Carlos Alberto Mandarim‐de‐Lacerda
Topics & Concepts
SemaglutideEndocrinologyInternal medicineIsletChemistryHeparan sulfateExtracellular matrixHeparanaseBiologyType 2 diabetesMedicineBiochemistryDiabetes mellitusLiraglutideHeparinDiabetes Treatment and ManagementPancreatic function and diabetesRegulation of Appetite and Obesity